We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-7.28%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.53B
AUM Growth
-$382M
Cap. Flow
+$195M
Cap. Flow %
2.99%
Top 10 Hldgs %
59.37%
Holding
305
New
83
Increased
54
Reduced
76
Closed
50

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$108M
2
BUD icon
AB InBev
BUD
+$39.8M
3
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$33.9M
4
CRL icon
Charles River Laboratories
CRL
+$32M
5
CL icon
Colgate-Palmolive
CL
+$27M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$93.3M
2
PFE icon
Pfizer
PFE
+$76.9M
3
JNJ icon
Johnson & Johnson
JNJ
+$53.7M
4
INCY icon
Incyte
INCY
+$46.6M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$45.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.38%
2 Consumer Staples 6.6%
3 Technology 4.23%
4 Consumer Discretionary 3.89%
5 Communication Services 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCL icon
276
Royal Caribbean
RCL
$85.6B
– –
-20,024
Closed -$2.08M
REAL icon
277
The RealReal
REAL
$1.48B
– –
-500,000
Closed -$1.11M
EZRA
278
Reliance Global Group
EZRA
$2.09M
– –
-228
Closed -$730K
SKIN icon
279
SkinHealth Systems
SKIN
$85.7M
– –
-200,000
Closed -$1.67M
SMPL icon
280
Simply Good Foods
SMPL
$982M
– –
-400,000
Closed -$14.6M
SPB icon
281
Spectrum Brands
SPB
$2.07B
– –
-73,000
Closed -$5.7M
STZ icon
282
Constellation Brands
STZ
$23.2B
– –
-60,000
Closed -$14.8M
TGNA
283
DELISTED
TEGNA Inc
TGNA
– –
-724,000
Closed -$11.8M
TSN icon
284
Tyson Foods
TSN
$20.4B
– –
-210,000
Closed -$10.7M
VSXY
285
Victoria's Secret
VSXY
$7.83B
– –
-266,769
Closed -$4.65M
XPOF icon
286
Xponential Fitness
XPOF
$211M
– –
-100,000
Closed -$1.73M
YYAI icon
287
AiRWA Inc
YYAI
$82.2K
– –
-1
Closed -$225K
AUMN
288
DELISTED
Golden Minerals Company
AUMN
– –
-686,413
Closed -$1.11M
BGXX
289
DELISTED
Bright Green Corporation Common Stock
BGXX
– –
-2,839,422
Closed -$2.87M
GROMW
290
DELISTED
Grom Social Enterprises Inc. Warrants
GROMW
– –
-24,100
Closed -$178K
OPGN
291
DELISTED
OpGen, Inc
OPGN
– –
-62,618
Closed -$510K
NBSE
292
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
– –
-166,174
Closed -$311K
YTEN
293
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
– –
-9,000
Closed -$480K
NTCO
294
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
– –
-358,767
Closed -$2.5M
HCDI
295
DELISTED
Harbor Custom Development, Inc. Common Stock
HCDI
– –
-98,000
Closed -$296K
FTCH
296
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
– –
-400,000
Closed -$2.42M
VAPO
297
DELISTED
Vapotherm, Inc. Common Stock
VAPO
– –
-471,250
Closed -$1.68M
SGEN
298
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-32,000
Closed -$6.16M
SQLLW
299
DELISTED
SeqLL Inc. Warrant
SQLLW
– –
-50,000
Closed -$3.92K
SURF
300
DELISTED
Surface Oncology, Inc. Common Stock
SURF
– –
-4,890,000
Closed -$4.25M
9 10 11
12
13

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Armistice Capital held 305 positions worth $6.53B, down 5.5% from $6.91B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Armistice Capital's Q3 2023 filing shows 83 new, 54 increased, 76 reduced and 50 closed positions. Its largest new stake was AB InBev: 703,000 shares worth $38.9M. The largest sale was Mirati Therapeutics, Inc. Common Stock, an estimated $93.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 39% a quarter earlier, followed by Consumer Staples and Technology.

  • Armistice Capital's largest Q3 2023 buy was AB InBev: 703,000 shares worth $38.9M.
  • Armistice Capital added most to PTC Therapeutics in Q3 2023, an estimated $108M increase.
  • Armistice Capital's biggest Q3 2023 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $93.3M.
  • Armistice Capital fully exited Pfizer in Q3 2023, selling an estimated $76.9M.
  • Armistice Capital's ten largest holdings make up 59% of its $6.53B portfolio in Q3 2023.
  • Armistice Capital opened 83 new positions and closed 50 in Q3 2023.
  • Armistice Capital's portfolio value fell 5.5% quarter-over-quarter to $6.53B.

Based on Armistice Capital's 13F filing for Q3 2023, filed 14 Nov 2023.